AC
WST icon

Apella Capital’s West Pharmaceutical WST Stock Holding History

Apella Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Buy
16,856
+18
+0.1% +$5.5K 0.08% 152
2026
Q1 		$4.61M Buy
16,838
+7
+0% +$1.74K 0.07% 166
2025
Q4 		$4.63M Buy
16,831
+8
+0% +$2.19K 0.09% 136
2025
Q3 		$4.49M Buy
16,823
+8
+0% +$1.94K 0.1% 128
2025
Q2 		$3.72M Buy
16,815
+15
+0.1% +$3.21K 0.1% 125
2025
Q1 		$3.42M Sell
16,800
-1
-0% -$276 0.12% 106
2024
Q4 		$5.5M Sell
16,801
-7
-0% -$2.2K 0.21% 74
2024
Q3 		$5.04M Buy
16,808
+13
+0.1% +$3.98K 0.21% 67
2024
Q2 		$5.35M Sell
16,795
-1
-0% -$353 0.24% 62
2024
Q1 		$6.59M Sell
16,796
-34
-0.2% -$12.6K 0.33% 54
2023
Q4 		$5.73M Sell
16,830
-115
-0.7% -$40.7K 0.32% 60
2023
Q3 		$6.36M Sell
16,945
-85
-0.5% -$32.9K 0.45% 47
2023
Q2 		$6.51M Buy
+17,030
New +$6.08M 0.46% 47
2022
Q4 		$4.1M Sell
17,400
-210
-1% -$49.8K 0.37% 54
2022
Q3 		$4.33M Sell
17,610
-200
-1% -$60.9K 0.5% 46
2022
Q2 		$5.38M Buy
17,810
+160
+0.9% +$52.1K 0.64% 37
2022
Q1 		$7.25M Buy
17,650
+4,000
+29% +$1.57M 1.02% 28
2021
Q4 		$6.4M Sell
13,650
-90
-0.7% -$38.7K 0.82% 32
2021
Q3 		$5.83M Sell
13,740
-135
-1% -$56.9K 0.84% 34
2021
Q2 		$4.98M Hold
13,875
– – 0.82% 32
2021
Q1 		$3.91M Hold
13,875
– – 1.23% 26
2020
Q4 		$3.93M Buy
13,875
+1,047
+8% +$294K 1.38% 23
2020
Q3 		$3.53M Hold
12,828
– – 1.42% 22
2020
Q2 		$2.91M Hold
12,828
– – 1.36% 20
2020
Q1 		$1.95M Buy
+12,828
New +$1.97M 1.14% 24

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Apella Capital's WST Position: Q2 2026 in Review

Apella Capital increased its West Pharmaceutical (WST) stake by 0.11% in Q2 2026, buying an estimated $5.5K and bringing the position to 16,856 shares worth $6M. The position accounts for 0.08% of the portfolio, ranked #152.

Apella Capital first reported a position in WST in Q1 2020 and has held it in 25 quarters since. The position peaked at $7.25M in Q1 2022. 99 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Apella Capital held 16,856 shares of West Pharmaceutical worth $6M as of Q2 2026.
  • Apella Capital bought 18 West Pharmaceutical shares in Q2 2026, an estimated $5.5K.
  • West Pharmaceutical made up 0.08% of Apella Capital's portfolio in Q2 2026, its #152 holding.
  • Apella Capital first reported a position in West Pharmaceutical in Q1 2020 and has held it in 25 quarters since.
  • Apella Capital's West Pharmaceutical position peaked at $7.25M in Q1 2022.
  • 99 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.